Milpharm Limited has identified a discrepancy in the Patient Information Leaflet (PIL) approved for Loperamide hydrochloride 2 mg Orodispersible Tablets.
Milpharm Limited has identified a discrepancy in the Patient Information Leaflet (PIL) approved for Loperamide hydrochloride 2 mg Orodispersible Tablets.
We use essential cookies to make our site work. With your permission, we'd also like to use Google Analytics cookies to understand how the site is used, and Google Ads cookies to measure our adverts. Read about cookies.